MedPath

INVASIX

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Study to Determine Safety and Efficacy of FPlus for Wrinkle Treatment

Not Applicable
Completed
Conditions
Facial Wrinkles and Rhytides Reduction
Interventions
Device: FPlus RF device for wrinkles and rhytide reduction
First Posted Date
2012-03-21
Last Posted Date
2012-03-21
Lead Sponsor
Invasix
Target Recruit Count
69
Registration Number
NCT01559233
Locations
🇨🇦

AestheticPlastic Surgery Practice, SpaMedica, Toronto, Canada

© Copyright 2025. All Rights Reserved by MedPath